Vertex宣佈其新藥Vanzacaftor / Tezacaftor / Deutiva

快訊 · 07/02 20:33

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis

Vertex宣佈其新藥Vanzacaftor / Tezacaftor / Deutivacaftor的新藥申請已獲FDA批准，這是一種用於治療囊性纖維化的下一代三聯療法。